The WHA 54.11 WHO medicines strategy acknowledged the four main objectives of WHO��s medicines strategy, namely, to frame and implement policy; to ensure access; to ensure quality, safety and efficacy; and to promote rational use of medicines. The WHO medicines strategy 2004-2007 presents the strate...
Problems related to the safety and quality of drugs exist in many places around the world today, in developing and developed countries alike. Some incidents have ended in tragedy, often with children as the victims. They are caused by the use of drugs containing toxic substances or impurities, drugs...
The Ministry of Health (MOH), through the Department of Pharmaceuticals and Natural Medicines (DPNM), executed the national integrated quantification for all Essential Medicines and Health Supplies (EMHS) for the financial year 2024/25.�As a result, the total commodity need for routine service deliv...
The thirty-ninth meeting of the World Health Organization (WHO) Expert Committee on Drug Dependence (ECDD) took place in Geneva, Switzerland from 6 to 10 November 2017. Dr Suzanne Hill, Director, WHO Department of Essential Medicines and Health Products (EMP), opened the meeting by welcoming all par...
The National Drug Authority Strategic Plan 2020/2021-2024/2025 builds on the gains achieved in the previous period and also focuses on consolidating efficiency and effectiveness in drug regulation, as provided for within the mandate of the Drug Authority. This strategic plan has been aligned to the...
The third National Pharmaceutical Sector Strategic Plan 2015/16-2019/20 (NPSSP III) has been developed to support the implementation of the National Medicines Policy (NMP) 2015. The NPSSP III was developed through wide consultations with diverse stakeholders including representatives from the privat...
The NMS Act Cap 207 states that the corporation shall advise the Ministry of Health, Ministry of Finance, Planning and Economic Development, Ministry of Local Government and National Drug Authority on essential issues relating to the state of the Corporation and its future development as well as to...
The Essential Medicines and Health Supplies List for�Uganda (EMHSLU) 2023 reflects the policy of the�Ministry of Health, for the appropriate procurement�of safe and efficacious essential medicines, health and�laboratory supplies in public institutions.�The EMHSLU 2023 was compiled based on�recommend...
The purpose of this report is to inform the Ministry of Health and all stakeholders of the stock levels in the country as a tool that enables appropriate logistics decision making . This report highlights stock status, real challenges, bottlenecks but also recommends potential solutions to mitigate...
Drug use, drug use disorders and related health conditions are major public health concerns. According to WHO��s latest estimates for 2015, psychoactive drug use is responsible for more than 450 000 deaths per year. The drug-attributable disease burden accounts for about 1.5% of the global burden of...
The WHO Expert Committee on Specifications for Pharmaceutical Preparations met in Geneva from 14 to 18 October 2013. Dr M.-P. Kieny, Assistant Director- General of Health Systems and Innovation at the World Health Organization (WHO), welcomed participants on behalf of the Director-General. Dr Kieny...
The thirty-seventh meeting of the WHO Expert Committee on Drug Dependence (ECDD) took place in Geneva, Switzerland from 16 to 20 November 2015. Mr Cornelis de Joncheere, Director, WHO Department of Essential Medicines and Health Products (EMP), opened the meeting. He welcomed all participants on beh...
The World Health Organization (WHO) Expert Committee on Specifications for Pharmaceutical Preparations (ECSPP) met in Geneva from 16 to 20 October 2017.Dr Suzanne R. Hill, acting Assistant Director of the Health Systems and Innovation Cluster and Director of the Department of Essential Medicines and...
The Ministry of Health (MOH), in collaboration with the U.S. Agency for International Development (USAID), the Global Fund to Fight AIDS, Tuberculosis and Malaria (The Global Fund), the USAID Global Health Supply Chain-Procurement and Supply Management (GHSC-PSM) project, and the USAID Uganda Health...
A drug and therapeutics committee (DTC) provides such a forum, allowing all the relevant people to work together to improve health care delivery, whether in hospitals or other health facilities. In many developed countries a well functioning DTC has been shown to be very effective in addressing drug...
The thirty-eighth meeting of the World Health Organization (WHO) Expert Committee on Drug Dependence (ECDD) took place in Geneva, Switzerland from 14 to 18 November 2016. Dr Suzanne Hill, Director, WHO Department of Essential Medicines and Health Products (EMP), opened the meeting. She welcomed all...
About 275 million people worldwide, which is roughly 5.6 per cent of the global population aged 15-64 years, used drugs at least once during 2016. Some 31 million of people who use drugs suffer from drug use disorders, meaning that their drug use is harmful to the point where they may need treatment...
Procurement planning is an annual exercise conducted by Health Facilities (HFs) countrywide with technical assistance from National Medical Stores (NMS) and under the supervision of Ministry of Health (MoH) with the objective of quantifying or determining facility pharmaceutical needs for the next f...
The schedue provides for control of 98 psychotropical substances which are assigned to one of the four schedues.
The organizations and agencies of the United Nations system and international and nongovernmental organizations are called upon to respond to an increasing number of largescale emergencies and disasters, many of which pose a serious threat to health. Much of the assistance provided in such situation...
